WDR45 Antibody [DyLight 405]
Novus Biologicals, part of Bio-Techne | Catalog # NBP3-18255V
Conjugate
Catalog #
Key Product Details
Species Reactivity
Validated:
Human, Rat
Applications
Immunocytochemistry/ Immunofluorescence, Western Blot
Label
DyLight 405 (Excitation = 400 nm, Emission = 420 nm)
Antibody Source
Polyclonal Rabbit IgG
Concentration
Please see the vial label for concentration. If unlisted please contact technical services.
Product Summary for WDR45 Antibody [DyLight 405]
Immunogen
Synthetic peptide from the C-terminal of Human WDR45(aa. 312-322)
Clonality
Polyclonal
Host
Rabbit
Isotype
IgG
Applications for WDR45 Antibody [DyLight 405]
Application
Recommended Usage
Immunocytochemistry/ Immunofluorescence
Optimal dilutions of this antibody should be experimentally determined.
Western Blot
Optimal dilutions of this antibody should be experimentally determined.
Application Notes
Optimal dilution of this antibody should be experimentally determined.
Please Note: Optimal dilutions of this antibody should be experimentally determined.
Formulation, Preparation, and Storage
Purification
Peptide affinity purified
Formulation
50mM Sodium Borate
Preservative
0.05% Sodium Azide
Concentration
Please see the vial label for concentration. If unlisted please contact technical services.
Shipping
The product is shipped with polar packs. Upon receipt, store it immediately at the temperature recommended below.
Stability & Storage
Store at 4C in the dark.
Background: WDR45
Alternate Names
JM5, WD repeat domain 45, WD repeat domain phosphoinositide-interacting protein 4, WD repeat-containing protein 45, WD45 repeat protein interacting with phosphoinositides 4, WDRX1, WDRXI4, WIPI-4, X-linked 1
Gene Symbol
WDR45
Additional WDR45 Products
Product Documents for WDR45 Antibody [DyLight 405]
Product Specific Notices for WDR45 Antibody [DyLight 405]
This product is for research use only and is not approved for use in humans or in clinical diagnosis. Primary Antibodies are guaranteed for 1 year from date of receipt.
Loading...
Loading...
Loading...
Loading...